- Home
- PLRX vs KIDS Comparison
PLRX vs KIDS Comparison
Compare PLRX & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- KIDS
- Stock Information
- Founded
- PLRX 2015
- KIDS 2007
- Country
- PLRX United States
- KIDS United States
- Employees
- PLRX N/A
- KIDS N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- KIDS Medical/Dental Instruments
- Sector
- PLRX Health Care
- KIDS Health Care
- Exchange
- PLRX Nasdaq
- KIDS Nasdaq
- Market Cap
- PLRX 680.3M
- KIDS 601.5M
- IPO Year
- PLRX 2020
- KIDS 2017
- Fundamental
- Price
- PLRX $11.37
- KIDS $24.26
- Analyst Decision
- PLRX Strong Buy
- KIDS Buy
- Analyst Count
- PLRX 7
- KIDS 6
- Target Price
- PLRX $40.50
- KIDS $37.67
- AVG Volume (30 Days)
- PLRX 485.5K
- KIDS 317.8K
- Earning Date
- PLRX 02-26-2025
- KIDS 03-05-2025
- Dividend Yield
- PLRX N/A
- KIDS N/A
- EPS Growth
- PLRX N/A
- KIDS N/A
- EPS
- PLRX N/A
- KIDS N/A
- Revenue
- PLRX N/A
- KIDS $189,673,000.00
- Revenue This Year
- PLRX N/A
- KIDS $39.26
- Revenue Next Year
- PLRX N/A
- KIDS $18.08
- P/E Ratio
- PLRX N/A
- KIDS N/A
- Revenue Growth
- PLRX N/A
- KIDS 33.47
- 52 Week Low
- PLRX $10.22
- KIDS $21.02
- 52 Week High
- PLRX $18.00
- KIDS $35.99
- Technical
- Relative Strength Index (RSI)
- PLRX 44.60
- KIDS 45.67
- Support Level
- PLRX $10.35
- KIDS $23.55
- Resistance Level
- PLRX $11.07
- KIDS $25.45
- Average True Range (ATR)
- PLRX 0.61
- KIDS 1.26
- MACD
- PLRX 0.06
- KIDS -0.28
- Stochastic Oscillator
- PLRX 43.50
- KIDS 20.48
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.